AI Health Technology Limited (HKG:1715)
Hong Kong · Delayed Price · Currency is HKD 0.4500
-0.0100 (-2.17%)
At close: Feb 12, 2026
AI Health Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 59.88 | 91.89 | 84.37 | 88.19 | 143.87 | 189.38 | |
Revenue Growth (YoY) | -32.43% | 8.91% | -4.33% | -38.71% | -24.03% | -23.11% |
Cost of Revenue | 57.29 | 85.4 | 63.15 | 49.7 | 78.6 | 94.39 |
Gross Profit | 2.59 | 6.49 | 21.22 | 38.49 | 65.27 | 94.99 |
Selling, General & Admin | 23.94 | 31.87 | 53.11 | 70.92 | 100.19 | 113.94 |
Research & Development | 5.33 | 5.87 | 6.94 | 7.99 | 10.54 | 10.69 |
Other Operating Expenses | -9.73 | -3.83 | -3.18 | -2.79 | -4.84 | -5.37 |
Operating Expenses | 23.57 | 37.93 | 62.58 | 78.19 | 105.88 | 120.66 |
Operating Income | -20.98 | -31.45 | -41.37 | -39.7 | -40.61 | -25.68 |
Interest Expense | -2.37 | -4.16 | -7.72 | -5.06 | -1.51 | -2.45 |
Interest & Investment Income | 0 | 0.01 | 0.01 | 0.06 | 0.09 | 0.54 |
Earnings From Equity Investments | -0.32 | -0.34 | -0.57 | -0.39 | -0.74 | 4.68 |
Currency Exchange Gain (Loss) | -0.55 | -0.55 | 0.05 | -0.94 | -0.95 | -2.55 |
EBT Excluding Unusual Items | -24.21 | -36.49 | -49.59 | -46.03 | -43.72 | -25.46 |
Gain (Loss) on Sale of Investments | 0.54 | 0.54 | 0.26 | -3.29 | - | 5.81 |
Gain (Loss) on Sale of Assets | - | - | -0.06 | 6.12 | -0.01 | -0.02 |
Pretax Income | -24.33 | -35.96 | -49.28 | -43.21 | -43.72 | -19.67 |
Income Tax Expense | 0.04 | 0.05 | 0.04 | 0.34 | 0.17 | 0.28 |
Earnings From Continuing Operations | -24.37 | -36.01 | -49.32 | -43.55 | -43.89 | -19.95 |
Minority Interest in Earnings | 0.17 | 0.16 | - | 0.34 | -0.46 | -1.18 |
Net Income | -24.2 | -35.85 | -49.32 | -43.21 | -44.35 | -21.13 |
Net Income to Common | -24.2 | -35.85 | -49.32 | -43.21 | -44.35 | -21.13 |
Shares Outstanding (Basic) | 129 | 97 | 68 | 60 | 60 | 60 |
Shares Outstanding (Diluted) | 129 | 97 | 68 | 60 | 60 | 60 |
Shares Change (YoY) | 73.18% | 42.94% | 12.70% | - | - | - |
EPS (Basic) | -0.19 | -0.37 | -0.73 | -0.72 | -0.74 | -0.35 |
EPS (Diluted) | -0.19 | -0.37 | -0.73 | -0.72 | -0.74 | -0.35 |
Free Cash Flow | -3.84 | -35.37 | 14 | -76.7 | -13.24 | -23.02 |
Free Cash Flow Per Share | -0.03 | -0.37 | 0.21 | -1.28 | -0.22 | -0.38 |
Gross Margin | 4.33% | 7.06% | 25.15% | 43.64% | 45.37% | 50.16% |
Operating Margin | -35.03% | -34.23% | -49.03% | -45.02% | -28.23% | -13.56% |
Profit Margin | -40.42% | -39.02% | -58.45% | -49.00% | -30.83% | -11.16% |
Free Cash Flow Margin | -6.42% | -38.50% | 16.59% | -86.97% | -9.20% | -12.15% |
EBITDA | -17.83 | -28.58 | -38.16 | -35.22 | -36.22 | -21.93 |
EBITDA Margin | -29.78% | -31.10% | -45.23% | -39.94% | -25.18% | -11.58% |
D&A For EBITDA | 3.14 | 2.87 | 3.21 | 4.48 | 4.39 | 3.75 |
EBIT | -20.98 | -31.45 | -41.37 | -39.7 | -40.61 | -25.68 |
EBIT Margin | -35.03% | -34.23% | -49.03% | -45.02% | -28.23% | -13.56% |
Advertising Expenses | - | - | - | 3.57 | 8.69 | 10.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.